Burroughs Amy L. 4

What Happened Amy L. Burroughs, a director of Tenaya Therapeutics, was granted a derivative equity award on May 28, 2026 covering 120,000 shares. The Form 4 reports an exercise/price per share of $0.00 and a reported transaction value of $0 — this filing reflects a grant (award), not a purchase or exercise.

Key Details

• Transaction date: 2026-05-28 (Form 4 filed 2026-05-29)
• Transaction type/code: A (Award/Grant of an option/derivative)
• Shares/options granted: 120,000
• Reported price per share: $0.00 (derivative award as reported)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnote: The option was granted under the 2021 Equity Incentive Plan and "will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date," subject to continued service (see F1)
• Filing timeliness: Filed one day after the transaction date (appears timely)

Context This is a compensation-related option grant to a board member, not an open-market purchase or sale. Such awards are common for directors and do not by themselves indicate buying or selling sentiment; the award vests over time, so any exercise or sale would be reported later on Form 4s.